BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Mirivadelgat readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Mirivadelgat\, from ClinicalTrials.gov es
 timates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06475781-543@assetmemo.bio
DTSTAMP:20261121T010150Z
DTSTART;VALUE=DATE:20280229
DTEND;VALUE=DATE:20280301
SUMMARY:Mirivadelgat: Phase 2 readout est. (NCT06475781)
DESCRIPTION:Mirivadelgat\, phase 2\, Pulmonary Hypertension Associated with
  Interstitial Lung Disease.\nStudy: Study to Evaluate Safety and Efficacy 
 of Mirivadelgat in PH-ILD (Windward)\nEstimated primary completion: Februa
 ry 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout d
 ate\, and it can move.\nDrug page: https://assetmemo.bio/drug/mirivadelgat
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT064
 75781
URL:https://assetmemo.bio/drug/mirivadelgat#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
